Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
about
Single nucleotide polymorphism of the human high affinity choline transporter alters transport rateMuscarinic agonists for the treatment of cognition in schizophreniaM4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition.F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.Disordered semantic representation in schizophrenic temporal cortex revealed by neuromagnetic response patternsLong-term effects of maternal deprivation on the neuronal soma area in the rat neocortex.Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.Regulation of cortical acetylcholine release: insights from in vivo microdialysis studiesDecreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.Projection-specific neuromodulation of medial prefrontal cortex neurons.Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophreniaCholinergic suppression of visual responses in primate V1 is mediated by GABAergic inhibition.Cholinergic circuits and signaling in the pathophysiology of schizophreniaAcute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.The biochemical womb of schizophrenia: A review.Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.Muscarinic acetylcholine receptors are expressed by most parvalbumin-immunoreactive neurons in area MT of the macaque.Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials.Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.Postnatal development of the basolateral complex of rabbit amygdala: a stereological and histochemical study.Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study.Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.
P2860
Q24306874-CBCFAE1B-3BBA-4867-A455-82AB2080EA5AQ28301970-F6F646BC-FC09-4B13-B7AA-25E361F8346CQ30467341-6D880CF8-7143-4006-85B1-F0093A7FBBECQ30494674-47517C06-AE83-4257-B7B7-DED73C2ABCB5Q30816570-CCCE6513-80BD-40C0-A987-B893621200D8Q33666686-4CAE29D6-A03F-46E5-86B7-E0A9D24FBC81Q33999521-3755985C-4A16-4C82-ACC9-59D4DB675379Q34077418-D4C507A2-8860-4FD5-934E-DED2EFC1AA64Q34163923-102E2370-E459-4FFF-BBA9-F88B3336CFF9Q34561031-076C3711-B90D-4125-81F1-08D7C0FE2734Q34788059-7371E05C-3EB8-49E6-8760-CFA68C3AEDA8Q35129327-A1F7C56D-9DFC-4013-B70B-5994DCF73606Q35356707-BCB2CDB6-12A5-41FA-B004-EECB929D8FE1Q36532534-10740901-0EE6-480B-B256-45C0EFD682E0Q36756379-544D800A-9263-4957-8BA3-FAA435D1A4BFQ36883052-C3EC98A3-1079-457E-809E-A04FE53882C0Q37212798-76B6CF72-F0D6-4E2B-B03E-AC9437E42A97Q37437840-1EA02503-AE06-4060-9CE2-A8317CD4B5C1Q38056122-1EA7D6EC-A47C-413C-8128-BF13AAE3F347Q38064198-7DF4D444-06A1-496E-9444-576F90A93AFDQ40630306-E56BCDAA-E04C-4BA8-939C-EED80AC3D58DQ42554387-7C48120E-157A-4E72-9DC0-49E969FE2F5EQ42580171-056197F1-3F71-49FD-97EC-3B3D19A105D6Q43198404-9B09597C-1191-4211-8915-EF9919C86A3AQ43546600-6FCB5D63-DA50-4950-ACD1-01E9B9359DB0Q44823857-66D04BD2-7C88-4646-AF3A-FE7D01E4A33FQ45215142-45E0FD84-5A8A-4F89-9671-4D2DEAFCEFF0Q47642665-2911CE04-F99A-4DC2-8E6B-C5725FB6D57BQ48106911-989F8FA8-4B5F-4320-AF62-35BE3BD52371Q48136570-34346824-A6E1-4B16-8792-C44629323C93Q48260619-68B66DCF-6A65-4A5B-97B8-B8BDA2B39659Q48428675-939E98F3-FC9A-4042-8E97-9100934C3BA0
P2860
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@ast
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@en
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@nl
type
label
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@ast
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@en
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@nl
prefLabel
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@ast
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@en
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@nl
P1476
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
@en
P2093
P356
10.1016/S0891-0618(01)00101-6
P577
2001-07-01T00:00:00Z